# SI-BONE, INC. (SIBN) · Edgar & Edgarette company card

> Si-Bone, Inc. (SIBN) grew revenue 20.2% in FY2025 to $201 million, operating margin -11.1% against a 1.2% median for surgical & medical instruments & apparatus, equity 74.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1459839 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SIBN) · [JSON](https://www.pops4.com/boards/company/SIBN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $201M |
| Revenue growth, 1 year | 20.2% |
| Revenue growth per year | 22.2% |
| Operating margin | -11.1% (prior year -21.1%) |
| Net margin | -9.4% |
| Operating cash flow | −$675,000 |
| Capital spending | $8M |
| Free cash flow | −$9M |
| Cash | $42M |
| Long-term debt | $36M |
| Total assets | $239M |
| Total equity | $178M |
| Equity ÷ assets | 74.4% |
| Return on equity | -10.6% |
| Dividend per share | $0 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 1.52 (grey zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.94 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -11.1% in FY2025
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $200.9M (FY2025), total debt $35.6M. Experience: revenue up 20.2% on the year, up 22.2% a year over 4 years; operating margin -11.1%, up from -21.1%. Soundness: equity 74.4% of assets, return on equity -10.6%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $210.8M and $273.1M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $197.5M to $292.4M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -11.1% against a 1.2% median; growth 20.2% against 11.6%.

Range logged 2026-09-24, receipt 3efdec3a31a66848, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-02-23 ([filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000022/0001459839-26-000022-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000086/0001459839-26-000086-index.htm)
- 8-K · filed 2026-11-02 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000084/0001459839-26-000084-index.htm)
- 8-K · filed 2026-09-11 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000076/0001459839-26-000076-index.htm)
- 10-Q · filed 2026-08-04 · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000069/0001459839-26-000069-index.htm)
- 8-K · filed 2026-08-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000066/0001459839-26-000066-index.htm)
- 8-K · filed 2026-06-08 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1459839/000145983926000059/0001459839-26-000059-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001459839.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1459839

## Cite

POPS4, Edgar & Edgarette: SI-BONE, INC. (SIBN) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SIBN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.